Form 8-K - Current report:
SEC Accession No. 0001193125-25-137105
Filing Date
2025-06-06
Accepted
2025-06-06 16:30:20
Documents
13
Period of Report
2025-06-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d61441d8k.htm   iXBRL 8-K 30960
  Complete submission text file 0001193125-25-137105.txt   191756

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA oaccu-20250603.xsd EX-101.SCH 3520
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oaccu-20250603_def.xml EX-101.DEF 14315
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE oaccu-20250603_lab.xml EX-101.LAB 23856
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oaccu-20250603_pre.xml EX-101.PRE 15213
16 EXTRACTED XBRL INSTANCE DOCUMENT d61441d8k_htm.xml XML 7438
Mailing Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071 213-830-6300
Oaktree Acquisition Corp. III Life Sciences (Filer) CIK: 0002029769 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42383 | Film No.: 251031158
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)